Abstract:Three new glycosides have been obtained from the herb Halenia elliptica D. Don (Genti- anaceae) which is used for treatment of liver diseases in Qinghai-Tibetan folk. Their structu- res have been identified as 1-O-[β-D-xylopyranosyl-(1→6)-β-D-glucopyranosyl]-2,3,5,7-terameth-oxyxanthone(Ⅰ) or as l-O-primeverosyl-2,3,5,7-tetramethoxyxanthone),1-O-[β-D-xylopyranosyl-(1-6)-β-D-glucopyranosyl]-2,3,5-trimethoxyxanthone (Ⅱ, or as 1-O-primeverosyl-2,3,5-trimeth- oxyxanthone), and 1-O-[β-D-xylopyranosyl-(1-6)-β-D-glucopyranosyl]-2,3,4,5-tetramethoxyxan- thone (Ⅲ, or as 1-O-primeverosyl-2,3,4,5-tetramethoxyxanthone) respectively, by means of che- mical and spectral methods. Ⅰ and Ⅱ are another two new antihepatitisic constituents of this species, and their biological activity of antihepatitis has been displayed by the pharmacological research. They were named haleniaside (Ⅰ) and demethoxyhaleniaside (Ⅱ).